Earnings History Data for AxoGen, Inc. (AXGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AxoGen, Inc.

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-05-2023	PM	7:00 AM ET (May 9)	AXGN	AxoGen, Inc.	401.31	-0.17	-0.25	-0.26	AxoGen GAAP EPS of -$0.10 beats by $0.12, revenue of $36.7M beats by $1.24M [5/9/2023 7:09 AM]	9.35	-0.31 (-3.21%)	0.0	0.0 (0.00%)	7.20 - 13.66	236,310	200,000	0
AxoGen Q1 2023 Earnings Preview [5/8/2023 1:31 PM] AxoGen GAAP EPS of -$0.10 beats by $0.12, revenue of $36.7M beats by $1.24M [5/9/2023 7:09 AM]
14-03-2023	PM	7:00 AM ET (Mar 14)	AXGN	AxoGen, Inc.	341.25	-0.13	-0.19	-0.12	AxoGen Non-GAAP EPS of -$0.03 beats by $0.08, revenue of $36.2M in-line [3/14/2023 7:09 AM]	8.44	0.91 (12.02%)	6.60	-0.93 (-12.35%)	6.87 - 13.66	610,578	180,000	3,044
AxoGen Q4 2022 Earnings Preview [3/13/2023 1:53 PM] AxoGen Non-GAAP EPS of -$0.03 beats by $0.08, revenue of $36.2M in-line [3/14/2023 7:09 AM]
08-11-2022	PM	4:00 AM ET (Nov 8)	AXGN	AxoGen, Inc.	452.01	-0.01	-0.15	-0.16	AxoGen reports Q3 earnings beat; narrows FY22 guidance [11/8/2022 7:22 AM]	12.04	1.36 (12.69%)	10.98	0.30 (2.81%)	6.87 - 14.59	247,914	170,000	504
AxoGen reports Q3 earnings beat; narrows FY22 guidance [11/8/2022 7:22 AM] Axogen, Inc Reports 2022 Third Quarter Financial Results [Nov-08-22 07:00AM]
03-08-2022	AH	4:05 PM ET (Aug 3)	AXGN	AxoGen, Inc.	386.22	-0.06	-0.15	-0.18	AxoGen Q2 Non-GAAP EPS of -$0.06, revenue of $34.5M, guidance affirmed [8/3/2022 4:31 PM]	10.49	0.03 (0.29%)	3.92	-0.40 (-9.26%)	6.87 - 20.12	147,223	220,000	51,552
AxoGen Q2 Non-GAAP EPS of -$0.06, revenue of $34.5M, guidance affirmed [8/3/2022 4:31 PM]
04-05-2022	AH	4:35 PM ET (May 4)	AXGN	AxoGen	304.00	-0.26	-0.17	0.00	AxoGen Non-GAAP EPS of -$0.20 misses by $0.05, revenue of $31M beats by $0.66M [5/4/2022 5:09 PM]	9.73	1.47 (17.80%)	8.95	0.69 (8.35%)	6.87 - 23.94	1,814,660	350,000	9,082
AxoGen Non-GAAP EPS of -$0.20 misses by $0.05, revenue of $31M beats by $0.66M [5/4/2022 5:09 PM] Axogen stock rises 9% after Q1 revenue beat, outlook 'on track' [5/5/2022 8:57 AM] Axogen, Inc Reports 2022 First Quarter Financial Results [May-04-22 04:05PM] Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft [May-04-22 04:01PM] AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 07:45PM] Axogen Aces Phase 3 Study For Avance Nerve Graft [May-05-22 10:58AM]
22-02-2022	AH	4:00 PM ET (Feb 22)	AXGN	AxoGen, Inc.	310.47	-0.12	-0.18	-0.15	AxoGen Non-GAAP EPS of -$0.08 beats by $0.05, revenue of $31.53M misses by $0.11M [2/22/2022 4:40 PM]	7.99	0.73 (10.06%)	7.26	0.0 (0.00%)	6.98 - 23.94	831,943	320,000	1,924
AxoGen Non-GAAP EPS of -$0.08 beats by $0.05, revenue of $31.53M misses by $0.11M [2/22/2022 4:40 PM] Axogen, Inc. Reports 2021 Fourth Quarter and Full-Year Financial Results [Feb-22-22 04:34PM] AxoGen (AXGN) Reports Q4 Loss, Tops Revenue Estimates [Feb-22-22 06:15PM]
03-11-2021	AH	4:00 PM ET (Nov 3)	AXGN	AxoGen, Inc.	630.06	-0.16	-0.19	-0.04	AxoGen EPS beats by $0.05, misses on revenue [11/3/2021 4:18 PM]	13.20	-2.40 (-15.38%)	15.00	-0.60 (-3.85%)	12.55 - 23.94	893,944	130,000	5,779
AxoGen EPS beats by $0.05, misses on revenue [11/3/2021 4:18 PM] Axogen, Inc. Reports 2021 Third Quarter Financial Results [Nov-03-21 04:01PM] AxoGen (AXGN) Reports Q3 Loss, Misses Revenue Estimates [Nov-03-21 05:15PM] AxoGen, inc (AXGN) Q3 2021 Earnings Call Transcript [Nov-03-21 09:31PM] Axogen, Inc. to Participate at Jefferies London Healthcare Conference [Nov-04-21 07:00AM]
04-08-2021	AH	4:00 PM ET (Aug 4)	AXGN	AxoGen, Inc.	835.65	-0.18	-0.18	-0.20	AxoGen EPS misses by $0.06, beats on revenue [8/4/2021 4:28 PM]	19.38	0.08 (0.41%)	18.78	-0.52 (-2.69%)	10.41 - 23.94	221,734	90,000	1,412
AxoGen EPS misses by $0.06, beats on revenue [8/4/2021 4:28 PM] Axogen, Inc. Reports 2021 Second Quarter Financial Results [Aug-04-21 04:01PM] AxoGen (AXGN) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 05:55PM] AxoGen, inc (AXGN) Q2 2021 Earnings Call Transcript [Aug-05-21 04:30AM]
05-05-2021	AH	4:00 PM ET (May 5)	AXGN	AxoGen, Inc.	763.24	-0.15	-0.20	-0.21	AxoGen EPS beats by $0.07, beats on revenue [5/5/2021 4:28 PM]	22.08	2.44 (12.42%)	20.05	0.41 (2.09%)	7.65 - 22.89	812,070	230,000	1,029
AxoGen, Inc. to Host Earnings Call [May-05-21 02:45PM] Axogen, Inc. Reports 2021 First Quarter Financial Results [May-05-21 04:00PM] AxoGen Inc (AXGN) Q1 2021 Earnings Call Transcript [May-06-21 12:31AM] Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference [May-06-21 07:00AM] AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 05:15PM]
22-02-2021	AH	4:00 PM ET (Feb 22)	AXGN	AxoGen, Inc.	801.00	-0.15	-0.16	-0.18	AxoGen EPS beats by $0.03, beats on revenue [2/22/2021 4:30 PM]	21.21	0.02 (0.09%)	22.25	1.06 (5.00%)	7.16 - 22.89	720,948	292,668	214
AxoGen EPS beats by $0.03, beats on revenue [2/22/2021 4:30 PM] Axogen, Inc. Reports 2020 Fourth Quarter and Full-Year Financial Results [Feb-22-21 04:01PM] AxoGen, Inc. to Host Earnings Call [Feb-22-21 02:30PM]
29-10-2020	AH	4:00 PM ET (Oct 29)	AXGN	AxoGen, Inc.	502.66	-0.04	-0.18	-0.13	AxoGen EPS beats by $0.18, beats on revenue [10/29/2020 4:18 PM]	12.43	-0.30 (-2.36%)	13.00	0.27 (2.12%)	7.16 - 18.84	463,759	244,386	550

05-08-2020	AH	4:00 PM ET (Aug 5)	AXGN	AxoGen, Inc.	452.09	-0.20	-0.33	-0.16	AxoGen EPS beats by $0.21, beats on revenue [8/5/2020 4:21 PM]	12.06	-0.24 (-1.99%)	12.70	0.39 (3.17%)	7.16 - 18.84	250,865	264,674	1,700

06-05-2020	AH		AXGN	AxoGen, Inc.	385.86	-0.21	-0.20	-0.21		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0